Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ABC Survival: Propofol vs Sevoflurane in Brain Cancer
NCT04962672Recruiting
- Sponsor
- University Health Network
- Start
- Jan 2022
- Primary completion
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of propofol injection (veterinary) in glioblastoma (GBM) and glioma (2 arms), sponsored by University Health Network. Primary endpoints: Rate of recruitment at 6 months, Retention rate at 6 months and 1 more. Started Jan 2022; status: recruiting.
02
Drugs
propofol injection (veterinary)
03
Conditions
glioblastoma (GBM)glioma
Beyond the preview
Go deeper on NCT04962672.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04962672.